First Time Loading...

Meridian Bioscience Inc
NASDAQ:VIVO

Watchlist Manager
Meridian Bioscience Inc Logo
Meridian Bioscience Inc
NASDAQ:VIVO
Watchlist
Price: 33.97 USD Market Closed
Updated: May 13, 2024

Meridian Bioscience Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Meridian Bioscience Inc
Operating Income Peer Comparison

Comparables:
COO
XRAY
ALGN
LNTH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Meridian Bioscience Inc
NASDAQ:VIVO
Operating Income
$75.6m
CAGR 3-Years
25%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Cooper Companies Inc
NYSE:COO
Operating Income
$536.7m
CAGR 3-Years
17%
CAGR 5-Years
5%
CAGR 10-Years
5%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Operating Income
$281m
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
Align Technology Inc
NASDAQ:ALGN
Operating Income
$663.9m
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
14%
Lantheus Holdings Inc
NASDAQ:LNTH
Operating Income
$474.4m
CAGR 3-Years
541%
CAGR 5-Years
49%
CAGR 10-Years
N/A

See Also

What is Meridian Bioscience Inc's Operating Income?
Operating Income
75.6m USD

Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Operating Income amounts to 75.6m USD.

What is Meridian Bioscience Inc's Operating Income growth rate?
Operating Income CAGR 5Y
11%

Over the last year, the Operating Income growth was -26%. The average annual Operating Income growth rates for Meridian Bioscience Inc have been 25% over the past three years , 11% over the past five years .